US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling by ...

Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14% on an operational basis due to ...

CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one large employer in ...

It's been a sad week for Moderna, Inc. (NASDAQ:MRNA), who've watched their investment drop 14% to US$46.83 in the week since the company reported its third-quarter result. In addition to smashing ...

Income Tax: $8 million for the third quarter. Earnings Per Share: $0.03 for the quarter. Moderna Inc (NASDAQ:MRNA) reported $1.9 billion in revenue for the third quarter, with a net income of $13 ...

Shares of Moderna Inc. MRNA shed 6.86% to $46.83 Friday, on what proved to be an all-around favorable trading session for the ...

Shares of Moderna Inc. MRNA slid 8.71% to $42.75 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.06% to ...

Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...

Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over ...

Headquartered in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a biotechnology company specializing in messenger RNA ...

Shares of biopharma companies levered to COVID-19 vaccines tumbled on Thursday after President-elect Donald Trump picked ...

Moderna has further expanded its Massachusetts real estate holdings ... secured two leases at its 96K SF office building at ...